CatalystEarnings

$JAZZ — JAZZ PHARMACEUTICALS PLC

JAZZ

$234.66

+2.14%

LLY

$1417.99

+0.61%

JNJ

$276.32

+3.81%

What changed

FQ2 FY2026 (ends Jun) | reported Aug 03: - Revenue: $1.21B - Adj EPS: $5.71 vs $6.18 🔴 - GAAP op margin: 20.5% (📈 +86.2pp YoY) Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $4.60B-$4.75B Also in play: $LLY $JNJ $ABBV $UNH $MRK

Why it matters

FQ2 FY2026 (ends Jun) | reported Aug 03:

Sources

pipeline